Medincell SA
PAR:MEDCL

Watchlist Manager
Medincell SA Logo
Medincell SA
PAR:MEDCL
Watchlist
Price: 14.8 EUR -0.67% Market Closed
Market Cap: 489.4m EUR

Wall Street
Price Targets

MEDCL Price Targets Summary
Medincell SA

Wall Street analysts forecast MEDCL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDCL is 22.25 EUR with a low forecast of 18.48 EUR and a high forecast of 26.25 EUR.

Lowest
Price Target
18.48 EUR
25% Upside
Average
Price Target
22.25 EUR
50% Upside
Highest
Price Target
26.25 EUR
77% Upside
Medincell SA Competitors:
Price Targets
600993
Mayinglong Pharmaceutical Group Co Ltd
52% Upside
4568
Daiichi Sankyo Co Ltd
69% Upside
KLBF
Kalbe Farma Tbk PT
53% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
50% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
87% Upside
4577
Daito Pharmaceutical Co Ltd
4% Downside
DHG
Dhg Pharmaceutical Joint-Stock Co
12% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
29% Downside

Revenue
Forecast

Revenue Estimate
Medincell SA

For the last 5 years the compound annual growth rate for Medincell SA's revenue is 44%. The projected CAGR for the next 3 years is 117%.

44%
Past Growth
117%
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medincell SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Medincell SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDCL's stock price target?
Price Target
22.25 EUR

According to Wall Street analysts, the average 1-year price target for MEDCL is 22.25 EUR with a low forecast of 18.48 EUR and a high forecast of 26.25 EUR.

What is Medincell SA's Revenue forecast?
Projected CAGR
117%

For the last 5 years the compound annual growth rate for Medincell SA's revenue is 44%. The projected CAGR for the next 3 years is 117%.

Back to Top